Study Shows a 78% Risk Decrease in Overall Incidence of Post-procedural AKI Dr. Michael Flaherty presents a more contemporary analysis of acute kidney injury (AKI) in patients undergoing high-risk PCI with Impella® support. As interviewer Dr. Shon Chakrabarti notes, data from the PROTECT II randomized, controlled clinical trial revealed that the Impella arm of the … Continue reading “Does Impella Affect Predicted AKI Risk?”
Tag: Acute Kidney Injury
Study shows lower than predicted incidence of post-procedural AKI in Protected PCI patients Dr. Seth Bilazarian, chief medical officer at Abiomed, discusses AKI data from the paper published by Flaherty, et. al, in Catheterization and Cardiac Intervention. This data is in addition to existing data and abstracts published by Flaherty, et al, and Westenfeld, et. … Continue reading “Summary of AKI Data with Impella Unloading”
Dr. Michael Flaherty discusses the retrospective, single-center study published in Circulation Research which finds that use of hemodynamic support with Impella 2.5® heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had preexisting kidney disease and low ejection fraction (EF). The new study … Continue reading “Impella® Heart Pump and Reduced Occurrence of Acute Kidney Injury in High-Risk PCI”
- Contrast-induced acute kidney injury caused by iodinated contrast medium is associated with high morbidity and mortality in at-risk patients.
- Previous studies note that automated contrast injectors, removal of contrast from the coronary sinus, and pressure-sensitive diversion devices may help reduce contrast exposure and lower the risk for AKI.